Close
Biotechgate
| |

Home Page

News in the Life Sciences Industry

Results 61 - 80 out of 500 displayed.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
Reset 

Ping An Strategically Invests in Tsumura and Becomes Its Largest Shareholder

HONG KONG and SHANGHAI, Sept. 22, 2017 /PRNewswire/ -- Ping An Insurance (Group) Company of China, Ltd. (hereinafter "Ping An" or the "Group", HKEx: 2318; SSE: 601318) has announced that it has entered into a strategic cooperation agreement with TSUMURA & CO. (hereinafter "Tsumura", stock... Read more ››

By: PR Newswire Association LLC. - 22 Sep 2017

China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 7, 2017

HONG KONG, Sept. 22, 2017 /PRNewswire/ -- China Cord Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company will hold its... Read more ››

By: PR Newswire Association LLC. - 22 Sep 2017

DSM - Repurchase of Shares (15 - 21 September 2017)

HEERLEN, The Netherlands, September 22, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Sep 2017
Related companies:  DSM

Natera Selected for Circulating Tumor DNA Study in Bladder Cancer

Denmark's Aarhus University to Use Signatera™ ctDNA Technology in Longitudinal Study

Read more ››
By: PR Newswire Association LLC. - 22 Sep 2017
Related companies:  Natera, Inc.

Immunoassays Show Strength: Watch These Three Areas

ROCKVILLE, Md., Sept. 22, 2017 /PRNewswire/ -- Immunoassays have long been the traditional testing type in in vitro diagnostics, and have been less of a focus of testing industry watchers while molecular approaches have received much attention. But this is changing according to a report from... Read more ››

By: PR Newswire Association LLC. - 22 Sep 2017

Daily Technical Summary Reports on Generic Drugs Stocks -- Adamas Pharma, Eagle Pharma, Neos Therapeutics, and Zynerba Pharma

NEW YORK, September 22, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Sep 2017
Related companies:  Adamas Pharmaceuticals, Inc. | Neos Therapeutics, Inc. | Eagle Pharmaceuticals Inc. | Zynerba Pharmaceuticals, Inc.

Technical Snapshots for These Biotech Stocks -- ImmunoCellular Therapeutics, Protalix BioTherapeutics, Synthetic Biologics, and Abeona Therapeutics

NEW YORK, September 22, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Sep 2017
Related companies:  Abeona Therapeutics, Inc.

Arthur Bedrosian, Lannett CEO, Prevails In Lawsuit With Internal Revenue Service

PHILADELPHIA, Sept. 22, 2017 /PRNewswire/ -- Arthur Bedrosian, chief executive officer of Lannett Company, Inc. (NYSE: LCI), has prevailed in his lawsuit with the U.S. Internal Revenue Service (IRS).

Read more ››
By: PR Newswire Association LLC. - 22 Sep 2017
Related companies:  Lannett Company, Inc.

Mallinckrodt Advocates for Comprehensive, Multi-Prong Action Plan to Fight Opioid Abuse and Misuse in the United States

ST. LOUIS, Sept. 22, 2017 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), an industry leader in the effort to address prescription drug diversion and misuse in the United States, today outlined its "Prescription for America's Opioid Epidemic" - six integrated policy initiatives that the company... Read more ››

By: PR Newswire Association LLC. - 22 Sep 2017
Related companies:  Mallinckrodt Institute of Radiology | Mallinckrodt Pharmaceutic

AbbVie and Bristol-Myers Squibb Announce Clinical Research Collaboration to Evaluate a Therapeutic Regimen in Advanced Solid Tumors

NORTH CHICAGO, Ill. and NEW YORK, Sept. 22, 2017 /PRNewswire/ -- AbbVie (NYSE: ABBV) and Bristol-Myers Squibb Company (NYSE: BMY) today announced a clinical trial... Read more ››

By: PR Newswire Association LLC. - 22 Sep 2017
Related companies:  AbbVie Inc. | Bristol-Myers Squibb

Drug Makers Stocks on Investors' Radar -- Alliqua BioMedical, Immune Pharma, Eli Lilly, and Merck

NEW YORK, September 22, 2017 /PRNewswire/ --

Read more ››
By: PR Newswire Association LLC. - 22 Sep 2017

Bone Therapeutics SA and Asahi Kasei sign exclusive license agreement for PREOB® in Japan

Read more ››
By: Nasdaq / GlobenewsWire - 22 Sep 2017
Related companies:  Bone Therapeutics S. A.

Invitation to the extraordinary shareholders' meeting

Read more ››
By: Nasdaq / GlobenewsWire - 22 Sep 2017
Related companies:  argenx SE

Novartis and The Max Foundation transform pioneering cancer access program for people in lower-income countries

Read more ››
By: Nasdaq / GlobenewsWire - 22 Sep 2017
Related companies:  Novan Therapeutics

Orion Pharma scientists led research group wins award for study paper on dexmedetomidine oromucosal gel for noise anxiety in dogs

Read more ››
By: Nasdaq / GlobenewsWire - 22 Sep 2017
Related companies:  Orion Corporation

Merck Opens China's First BioReliance® End-to-End Biodevelopment Center in Shanghai

- Company's first end-to-end center outside of Europe

Read more ››
By: PR Newswire Association LLC. - 22 Sep 2017
Related companies:  Merck KGaA | Merck & Co., Inc. | Merck Ventures

MilliporeSigma Opens China's First BioReliance® End-to-End Biodevelopment Center in Shanghai

- Company's first end-to-end center outside of Europe

Read more ››
By: PR Newswire Association LLC. - 22 Sep 2017

VolitionRx Limited Awarded $1.5 Million in Non-Dilutive Funding

ISNES, Belgium, Sept. 21, 2017 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that it has been awarded a loan and a non-repayable grant totaling $1.5 million from SOFINEX and the Walloon Region, Belgium. This is in addition to the $947,000 in loans previously... Read more ››

By: PR Newswire Association LLC. - 21 Sep 2017
Related companies:  VolitionRX Ltd

PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH PLAINFIELD, N.J., Sept. 21, 2017 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that on September 18, 2017 it approved non-statutory stock options to purchase an aggregate of 32,500 shares of its common stock to thirteen new employees. The awards were made pursuant... Read more ››

By: PR Newswire Association LLC. - 21 Sep 2017
Related companies:  PTC Therapeutics, Inc.

Nektar Therapeutics Appoints Biotechnology Executive Jeff Ajer as New Board Member

SAN FRANCISCO, Sept. 21, 2017 /PRNewswire/ -- Nektar Therapeutics (Nasdaq: NKTR) today announced that Jeff Ajer, Executive Vice President and Chief Commercial Officer of BioMarin, has been appointed as an independent director to Nektar's Board of Directors. Mr. Ajer has more than 25 years of... Read more ››

By: PR Newswire Association LLC. - 21 Sep 2017
Related companies:  Nektar Therapeutics Inc.
«  1  2  3 4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »
to the top ↑